Ninety One UK Ltd Has $90.84 Million Holdings in CME Group Inc. $CME

Ninety One UK Ltd lifted its stake in shares of CME Group Inc. (NASDAQ:CME) by 34.5% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 329,576 shares of the financial services provider’s stock after buying an additional 84,602 shares during the period. Ninety One UK Ltd owned about 0.09% of CME Group worth $90,838,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the company. Webster Bank N. A. boosted its stake in shares of CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 60 shares in the last quarter. Highline Wealth Partners LLC increased its stake in shares of CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 43 shares during the period. Wayfinding Financial LLC acquired a new stake in CME Group during the 1st quarter worth approximately $25,000. Cornerstone Planning Group LLC boosted its position in CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after buying an additional 55 shares during the period. Finally, Golden State Wealth Management LLC increased its position in CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 98 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME stock opened at $270.19 on Wednesday. The company has a market cap of $97.37 billion, a price-to-earnings ratio of 26.16, a price-to-earnings-growth ratio of 4.93 and a beta of 0.43. CME Group Inc. has a 52 week low of $213.94 and a 52 week high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm has a 50 day moving average of $270.73 and a 200-day moving average of $271.13.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the firm earned $2.56 earnings per share. CME Group’s revenue was up 10.4% on a year-over-year basis. On average, equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s payout ratio is presently 48.40%.

Insider Transactions at CME Group

In other CME Group news, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the sale, the insider owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director William R. Shepard bought 262 shares of the business’s stock in a transaction that occurred on Thursday, September 25th. The stock was purchased at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the completion of the acquisition, the director owned 258,459 shares in the company, valued at $68,540,742.21. This represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

CME has been the subject of several analyst reports. Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Citigroup upgraded CME Group from a “neutral” rating to a “buy” rating and upped their price target for the company from $275.00 to $300.00 in a research report on Thursday, September 25th. Piper Sandler upped their price target on CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research report on Tuesday, July 15th. Oppenheimer lifted their price objective on CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a research note on Thursday, July 24th. Finally, UBS Group lowered their price target on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a report on Monday, September 8th. Five investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $268.14.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.